A Leap of Good Faith When Cries of They Copied Us Cannot Be Stopped
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Robert W. Servilio & Jeremy Anapol
LINE-NETICS, LLC v. NU TSAI CAPITAL LLC
Before Lourie, Taranto, and Stark. Appeal from the U.S. District Court for the District of Nebraska.
Summary: Courts cannot enjoin speech by patentholders to third parties alleging infringement where there is an objectively reasonable basis for the allegations.
Line-Netics sued Nu Tsai Capital (d.b.a. Holiday Bright Lights, “HBL”) for patent infringement. Line-Netics also sent notices to HBL’s customers, alleging, among other things, that HBL was infringing two Line-Netics patents. HBL filed state-law counterclaims, including for tortious interference and defamation, and moved to enjoin Line-Netics from sending such notices.
The district court granted a preliminary injunction forbidding Line-Netics from making statements suggesting HBL is a patent infringer. Because federal patent law and the First Amendment preempt “state-law liability for a patentholder’s good faith conduct in communications asserting infringement of its patent and warning about potential litigation,” bad faith was a prerequisite to this injunction. The district court found Line-Netics acted in bad faith because its allegations of infringement were “objectively baseless,” for a variety of reasons.
The Federal Circuit rejected each of the district court’s reasons for finding that the infringement allegations were “objectively baseless,” by identifying arguments supporting that the allegations were “at least reasonable.” Therefore, the Federal Circuit found that the district court abused its discretion by issuing the injunction.
Editor: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…